A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in vitro/vivo Evaluation [Retraction]
Drug Des Devel Ther
.
2022 Nov 18:16:4013-4014.
doi: 10.2147/DDDT.S398020.
eCollection 2022.
PMID:
36425307
PMCID:
PMC9680675
DOI:
10.2147/DDDT.S398020
Abstract
[This retracts the article DOI: 10.2147/DDDT.S81722.].
© 2022 Dove Medical Press.
Publication types
Retraction of Publication